MARÍA
CAMBRA PELLEJÀ
Investigador/a en el període 2019-2022
![Foto de MARÍA](/img/nophoto.png)
![Foto de Leiden University Medical Center](/img/noimage_org.png)
Leiden University Medical Center
Leiden, HolandaPublicacions en col·laboració amb investigadors/es de Leiden University Medical Center (5)
2022
-
An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol
Gates Open Research, Vol. 6
-
Ivermectin and albendazole coadministration: opportunities for strongyloidiasis control
The Lancet Infectious Diseases, Vol. 22, Núm. 11, pp. e341-e347
-
Single-Nucleotide Polymorphisms in the Beta-Tubulin Gene and Its Relationship with Treatment Response to Albendazole in Human Soil-Transmitted Helminths in Southern Mozambique
American Journal of Tropical Medicine and Hygiene, Vol. 107, Núm. 3, pp. 649-657
2021
-
Improving stool sample processing and pyrosequencing for quantifying benzimidazole resistance alleles in Trichuris trichiura and Necator americanus pooled eggs
Parasites and Vectors, Vol. 14, Núm. 1
-
Towards soil-transmitted helminths transmission interruption: The impact of diagnostic tools on infection prediction in a low intensity setting in Southern Mozambique
PLoS Neglected Tropical Diseases, Vol. 15, Núm. 10